Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Moderna, Inc. (MRNA)
Sector: Healthcare; Industry: Biotechnology

Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Moderna, Inc. also has a collaboration with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-04-15 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $158.76 $1,047,816 Yes
2021-04-15 Bancel Stephane Chief Executive Officer Sell 19,000 $156.39 $2,971,350 No
2021-04-14 Andres Juan nan Sell 5,000 $153.75 $768,750 Yes
2021-04-13 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $146.62 $967,692 Yes
2021-04-13 Hoge Stephen President Sell 20,000 $145.58 $2,911,600 Yes
2021-04-12 Zaks Tal Zvi Chief Medical Officer Sell 5,000 $138.96 $694,818 Yes
2021-04-12 Andres Juan nan Sell 5,000 $142.46 $712,300 Yes
2021-04-08 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $132.85 $876,810 Yes
2021-04-08 Bancel Stephane Chief Executive Officer Sell 19,000 $132.27 $2,513,170 No
2021-04-07 Andres Juan nan Sell 5,000 $131.63 $658,150 Yes
2021-04-06 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $130.01 $858,066 Yes
2021-04-05 Zaks Tal Zvi Chief Medical Officer Sell 5,000 $129.71 $648,530 Yes
2021-04-05 Andres Juan nan Sell 5,000 $132.63 $663,150 Yes
2021-04-05 Hoge Stephen President Sell 20,000 $132.63 $2,652,600 Yes
2021-04-05 Bancel Stephane Chief Executive Officer Sell 11,046 $129.77 $1,433,417 No
2021-04-01 Bancel Stephane Chief Executive Officer Sell 19,000 $127.11 $2,415,000 No
2021-04-01 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $132.51 $874,566 Yes
2021-03-30 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $123.30 $813,780 Yes
2021-03-31 Andres Juan nan Sell 5,000 $121.10 $605,500 Yes
2021-03-31 AFEYAN NOUBAR Director Sell 3,752,805 $121.43 $455,692,554 No
2021-03-26 Bancel Stephane Chief Executive Officer Sell 11,046 $132.76 $1,466,464 No
2021-03-29 Andres Juan nan Sell 5,000 $130.05 $650,250 Yes
2021-03-25 Bancel Stephane Chief Executive Officer Sell 19,000 $131.71 $2,502,430 No
2021-03-25 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $126.88 $837,408 Yes
2021-03-24 Hoge Stephen President Sell 20,000 $140.83 $2,816,618 Yes
2021-03-24 Andres Juan nan Sell 5,000 $137.07 $685,350 Yes
2021-03-22 Zaks Tal Zvi Chief Medical Officer Sell 1,199 $144.82 $173,640 Yes
2021-03-22 Andres Juan nan Sell 5,000 $144.19 $720,950 Yes
2021-03-19 Bancel Stephane Chief Executive Officer Sell 11,046 $142.64 $1,575,547 No
2021-03-18 HENDERSON LORI M. General Counsel and Secretary Sell 6,600 $144.39 $952,974 Yes

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.